Board of Directors- Dechra Pharmaceuticals PLC Annual Report & Accounts 2016

Audit

Nomination

Remuneration

Chairman

Michael Redmond

Non-Executive Chairman

Committee Membership

Nomination (Chairman), Remuneration.

Skills and Experience

Michael has extensive board level international pharmaceutical experience, having held Non-Executive Director and Chairman roles in a number of healthcare related companies, both private and public, in the UK, Germany and Canada. Furthermore, as a result of Michael's tenure with the Company, he has a detailed knowledge and understanding of Dechra.

Background

Michael joined the Company as a Non-Executive Director in April 2001, and was appointed Chairman in July 2002. He began his pharmaceutical career with Glaxo and went on to hold a number of senior positions within Schering Plough Corporation. In 1991, he joined Fisons plc and in 1993 was appointed to the Board as Managing Director of their pharmaceuticals division. Michael left Fisons in 1996 following its takeover by RPR. He also held the position of Chairman of Abcam PLC from February 2009 to November 2014.

External Appointments

None.

Ian Page

Chief Executive Officer

Committee Membership

Not applicable.

Skills and Experience

Ian has gained detailed knowledge and experience through various positions he has held within the pharmaceutical and veterinary arena. He has solid understanding of how business develops both in the UK and globally. In particular he has extensive experience in M&A and in the successful delivery of strategic plans.

Background

Ian joined NVS, Dechra's former services business, at its formation in 1989 and was an integral part of the MBO in 1997, becoming its Managing Director in 1998. He joined the Board in 1997 and became Chief Executive Officer in 2001. Ian has played a key role in the development of the Group's growth strategy.

External Appointments

In October 2010 Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management Limited.

Tony Griffin

Managing Director,
Dechra Veterinary Products EU

Committee Membership

Not applicable.

Skills and Experience

Tony has over 25 years' experience in the animal health business and has substantial international experience as a result of living and working outside the UK since 1993. He gained broad experience of running an international animal health business with teams in different European countries as Chief Executive Officer of the AUV Group. Tony is the Board nominated Director responsible for health, safety and environmental matters.

Background

Tony was appointed Managing Director of DVP EU in May 2012 following the acquisition of Eurovet^® Animal Health BV from AUV Holding B.V. He joined the AUV Group in 1993 as Director of Exports, having previously worked at Norbrook Laboratories and Moy Park. Tony was promoted to Managing Director of Eurovet in 1996, becoming the Chief Executive Officer of the AUV Group in 2006.

External Appointments

None.

Ishbel Macpherson

Senior Independent Non-Executive Director

Committee Membership

Audit, Nomination, Remuneration (Chairman).

Skills and Experience

Ishbel has a broad range of PLC Board experience in a variety of roles, including Chairman, Audit Committee and Remuneration Committee Chairman. She has knowledge and understanding of City matters gained over 20 years' experience as an investment banker, specialising in UK mid-market corporate finance.

Background

Ishbel joined the Group as a Non-Executive Director in February 2013. Prior to this she was Head of UK Emerging Companies Corporate Finance at Dresdner Kleinwort Benson from 1999 to 2005, having previously worked at Hoare Govett and Barclays de Zoete Wedd.

External Appointments

Ishbel is a Non-Executive Director at Galliford Try plc (appointed February 2014) and Senior Independent Director at Bonmarche Holdings plc (appointed October 2013).

Julian Heslop

Non-Executive Director

Committee Membership

Audit (Chairman), Nomination, Remuneration.

Skills and Experience

Julian has considerable financial experience as a result of the senior finance roles he has held in the pharmaceutical, food, property and brewing sectors over the last 30 years.

Background

Julian joined the Board in January 2013. He served as Chief Financial Officer of GlaxoSmithKline PLC between 2005 and 2011, having previously been appointed its Senior Vice President, Operations Controller between 2001 and 2005 and as Financial Controller of Glaxo Wellcome PLC between 1998 and 2000. Prior to this, Julian held senior finance roles at Grand Metropolitan PLC and Imperial Brewing and Leisure. He is a Fellow of the Institute of Chartered Accountants in England and Wales.

External Appointments

Julian is a Non-Executive Director at Revolymer PLC (appointed July 2012) and is their Audit Committee Chairman. He is also a Director, and Chairman of the Audit Committee, of the Royal Academy of Arts (appointed October 2012).

Tony Rice

Non-Executive Director

Committee Membership

Audit, Nomination, Remuneration.

Skills and Experience

Tony has extensive board level experience across a range of sectors, including aerospace, healthcare, telecommunications and retail in both UK and international markets.

Background

Tony joined the Board in May 2016. He served as Chief Executive Officer at Cable & Wireless and Tunstall Holdings, and prior to that held various roles at BAE Systems including Managing Director of Commercial Aircraft and Group MD of Business Development. He has also served as a Non-Executive Director at Punch Taverns, Spirit Pub Company, Cable & Wireless, Telewest Communications and Saab Technologies, and Chairman of Alexander Mann Solutions.

External Appointments

Tony is currently the Senior Independent Non-Executive Director and Chairman of the Remuneration Committee at Halma plc.

Suzana Cross

General Counsel and Company Secretary

Committee Membership

Not applicable.

Skills and Experience

Suzana has over 19 years' experience as a solicitor, having held positions both in private practice and in-house.

Background

Suzana was appointed as General Counsel and Company Secretary in November 2015. Prior to her appointment she was General Counsel and Company Secretary for Victrex plc from April 2012 to November 2015, General Counsel and Company Secretary for Speedy Hire plc from July 2009 to March 2012 and Senior Legal Adviser at United Utilities Group PLC from 2003 to 2008. Suzana has a corporate and commercial law background, having worked as a corporate lawyer at Herbert Smith in London and at DLA Phillips Fox in Sydney, Australia.

External Appointments

None.

Anne-Francoise Nesmes

Chief Financial Officer

Committee Membership

Not applicable.

Skills and Experience

Anne-Francoise has considerable experience in the pharmaceutical industry covering all finance activities including R&D, manufacturing, commercial and corporate finance.

Background

Anne-Francoise was appointed Chief Financial Officer in April 2013. Prior to joining the Group, Anne-Francoise worked at GlaxoSmithKline PLC for over 15 years, where she held a number of finance roles including Senior Vice-President, Finance, of the global vaccines business unit based in Belgium. Prior to this, she held finance roles with John Crane, Tetra Pak, ADP and Caterpillar UK.

External Appointments

None.

Anne-Francoise resigned on 31 July 2016.